MEDICREA announced that it has received FDA-Clearance for UNiD® IB3D Patient-Matched interbody cages which completes its UNiD® ASI platform technology. UNiD® IB3D Patient-Matched interbody cages are 3D-printed titanium implants which allow customization of the cage dimensions, features and endplate morphology. It is the first time that this level of customization is commercially available on the spinal device market. These cages are specifically defined to precisely match the optimal patient’s surgical and anatomical requirements, determined by the UNiD® LAB engineers during the pre-op planning phase. Through 3D reconstruction of the spine, the engineers map out the exact anatomy of each vertebrae endplates. They then design the ideal cage to restore proper height and angulation but also to offer an optimized surface contact between the implant and the vertebrae endplates in order to improve stability of the instrumented segment and reduce subsidence. With this new FDA clearance, MEDICREA® offers a solution that does not only meet standard clinical needs, but also provide surgeons with a solution that was not available to them before. UNiD® IB3D Patient-Matched interbody cages allow the surgeon to accommodate geometrical inconsistencies of endplates and vertebral bodies, thus improving surgical and clinical outcomes. UNiD® IB3D Patient-Matched interbody cages designed through the UNiD® ASI pre-operative surgical planning tool provide surgeons with accurate patient-specific implantable devices and help streamlining implant inventory in the operating room.